Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Pharmaceutical Manufacturing

Ahmedabad, Gujarat 222,671 followers

About us

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Website
http://www.torrentpharma.com
Industry
Pharmaceutical Manufacturing
Company size
10,001+ employees
Headquarters
Ahmedabad, Gujarat
Type
Public Company
Founded
1971
Specialties
Pharmaceuticals : Cardiovascular, Central Nervous System, Gastro-intestinal, Diabetology, Anti-infective and Pain management segments, and Women Healthcare

Locations

Employees at Torrent Pharmaceuticals Ltd

Updates

Similar pages

Browse jobs

Funding

Torrent Pharmaceuticals Ltd 1 total round

Last Round

Post IPO equity

US$ 40.0M

Investors

Chrys Capital
See more info on crunchbase